Infertility Diagnosis and Treatment Market Report: Trends, Forecast and Competitive Analysis to 2030

Infertility Diagnosis and Treatment Trends and Forecast

The future of the global infertility diagnosis and treatment market looks promising with opportunities in the male infertility treatment and female infertility treatment markets. The global infertility diagnosis and treatment market is expected to reach an estimated $2.9 billion by 2030 with a CAGR of 7.9% from 2024 to 2030. The major drivers for this market are declining fertility rate, increasing availability of various fertility treatment options, and rising number of fertility centers across the globe.

A more than 150-page report is developed to help in your business decisions.

Infertility Diagnosis and Treatment by Segment

The study includes a forecast for the global infertility diagnosis and treatment by diagnosis, treatment, and region.

Infertility Diagnosis and Treatment Market by Diagnosis [Shipment Analysis by Value from 2018 to 2030]:

• Male Infertility Diagnosis
• Female Infertility Diagnosis

Infertility Diagnosis and Treatment Market by Treatment [Shipment Analysis by Value from 2018 to 2030]:

• Male Infertility Treatment
• Female Infertility Treatment
• Others

Infertility Diagnosis and Treatment Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Infertility Diagnosis and Treatment Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies infertility diagnosis and treatment companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the infertility diagnosis and treatment companies profiled in this report include-

• Bayer AG
• Bristol-Myers Squibb
• Church & Dwight
• Cook Medical
• Coopersurgical
• Eli Lilly
• EMD Serono
• Endo Pharmaceuticals
• Ferring Pharmaceuticals
• Genea

Infertility Diagnosis and Treatment Market Insights

• Lucintel forecasts that female infertility diagnosis is expected to witness higher growth over the forecast period.

• Female infertility treatment will remain the largest segment.

• North America will remain the largest segment over the forecast period due to the changing lifestyle and growing geriatric population.

Features of the Global Infertility Diagnosis and Treatment Market

• Market Size Estimates: Infertility diagnosis and treatment market size estimation in terms of value ($B).

• Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

• Segmentation Analysis: Infertility diagnosis and treatment market size by diagnosis, treatment, and region. in terms of value ($B).

• Regional Analysis: Infertility diagnosis and treatment market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

• Growth Opportunities: Analysis of growth opportunities in different diagnosis, treatments, and region.s for the infertility diagnosis and treatment market.

• Strategic Analysis: This includes M&A, new product development, and competitive landscape of the infertility diagnosis and treatment market.

• Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1. What is the infertility diagnosis and treatment market size?

Answer: The global infertility diagnosis and treatment market is expected to reach an estimated $2.9 billion by 2030.

Q.2. What is the growth forecast for infertility diagnosis and treatment market?

Answer: The global infertility diagnosis and treatment market is expected to grow with a CAGR of 7.9% from 2024 to 2030.

Q.3. What are the major drivers influencing the growth of the infertility diagnosis and treatment market?

Answer: The major drivers for this market are declining fertility rate, increasing availability of various fertility treatment options, and rising number of fertility centers across the globe.

Q.4. What are the major segments for infertility diagnosis and treatment market?

Answer: The future of the global infertility diagnosis and treatment market looks promising with opportunities in the male infertility treatment and female infertility treatment markets.

Q.5. Who are the key infertility diagnosis and treatment market companies?

Answer: Some of the key infertility diagnosis and treatment companies are as follows:

• Bayer AG
• Bristol-Myers Squibb
• Church & Dwight
• Cook Medical
• Coopersurgical
• Eli Lilly
• EMD Serono
• Endo Pharmaceuticals
• Ferring Pharmaceuticals
• Genea

Q.6. Which infertility diagnosis and treatment market segment will be the largest in future?

Answer: Lucintel forecasts that female infertility diagnosis is expected to witness higher growth over the forecast period.

Q.7. In infertility diagnosis and treatment market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest segment over the forecast period due to the changing lifestyle and growing geriatric population.

Q.8. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the infertility diagnosis and treatment market by diagnosis (male infertility diagnosis and female infertility diagnosis), treatment (male infertility treatment, female infertility treatment, and Others), and region. (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?